Evidence map›Paper›PMID 32515017›Full record

ArticleAnnals of neurology2020

SCN3A-Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain Malformation.

Tariq Zaman, Katherine L Helbig, Jérôme Clatot, Christopher H Thompson, Seok Kyu Kang, Katrien Stouffs, Anna E Jansen, Lieve Verstraete, Adeline Jacquinet, Elena Parrini and 26 more

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. CRISPR/Cas9-mediatedFrontiers in physiology · 2026
    Article
  11. Article
  12. Article
  13. The Role ofBiomolecules · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Structural brain MRI abnormalities inFrontiers in neurology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 8 countries.

Tariq ZamanDivision of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Katherine L HelbigDivision of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-8249-0549
Jérôme ClatotDivision of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Christopher H ThompsonDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Seok Kyu KangDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Katrien StouffsCenter for Medical Genetics/Research Center for Reproduction and Genetics, University Hospital Brussels, Free University of Brussels, Brussels, Belgium.
Anna E JansenPediatric Neurology Unit, Department of Pediatrics, University Hospital Brussels, Brussels, Belgium.
Lieve VerstraeteChild Neurology, Heilig Hart Hospital Lier, Lier, Belgium.
Adeline JacquinetHuman Genetics Service, Sart Tilman University Hospital Center, Liege, Belgium.
Elena ParriniPediatric Neurology, Neurogenetics, and Neurobiology Unit and Laboratories, Department of Neuroscience, A. Meyer Children's Hospital, University of Florence, Florence, Italy.
Renzo GuerriniPediatric Neurology, Neurogenetics, and Neurobiology Unit and Laboratories, Department of Neuroscience, A. Meyer Children's Hospital, University of Florence, Florence, Italy.
Yuh FujiwaraDepartment of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Bruria Ben-ZeevPediatric Neurology Unit, Edmond and Lili Safra Children's Hospital, Haim Sheba Medical Center, Ramat Gan, Israel.
Haim BassanSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Orit ReishSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Daphna MaromSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Natalie HauserInova Translational Medicine Institute, Inova Health System, Fairfax, Virginia, USA.
Thuy-Anh VuDepartment of Pediatric Neurology, Children's National Medical Center, Washington, District of Columbia, and Pediatric Specialists of Virginia, Fairfax, Virginia, USA.
Sally AckermannDivision of Paediatric Neurology, Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.
Careni E SpencerDivision of Human Genetics, Department of Medicine, University of Cape Town, South Africa and Groote Schuur Hospital, Cape Town, South Africa.
Natalie LippaInstitute for Genomic Medicine, Columbia University Medical Center, New York, New York, USA.
Shraddha SrinivasanDepartment of Neurology, Columbia University Medical Center, New York, New York, USA.
Agnieszka CharzewskaDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Dorota Hoffman-ZacharskaDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
David FitzpatrickMedical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Victoria HarrisonWessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom.
Pradeep VasudevanDepartment of Clinical Genetics, University Hospitals Leicester National Health Service Trust, Leicester, United Kingdom.
Shelagh JossWest of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Daniela T PilzWest of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Katherine A FawcettMedical Research Council (MRC) Computational Genomics Analysis and Training Programme, MRC Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
Ingo HelbigDivision of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-8486-0558
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Jennifer A KearneyDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0003-1726-4769
Andrew E FryDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Ethan M GoldbergDivision of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-7404-735X
Children's Hospital of Philadelphia · USTel Aviv University · ILNorthwestern University · USColumbia University Irving Medical Center · USMeyer Children's Hospital · ITQueen Elizabeth University Hospital · GBUniversity of Cape Town · ZAYokohama City University · JPCenter for Human Genetics · USChildren's National · USErasmus Hospital · BEHartcentrum Hasselt · BEInova Health System · USInstitute of Genetics and Cancer · GBJohn Radcliffe Hospital · GBNational Health Service · GBPrincess Anne Hospital · GBUniversity Hospital of Wales · GBUniversity of Liège · BEYokohama City University Medical Center · JP

Funding

Pathomechanisms of SCN3A-related neurodevelopmental disorderR01NS119977 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI GOLDBERG, ETHAN M · 2021 to 2025
$2.7M
Dynamic two-photon calcium imaging and optogenetic manipulation of epileptic brain circuits in an experimental model of temporal lobe epilepsyK08NS097633 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI GOLDBERG, ETHAN M · 2016 to 2020
$921k
NINDS NIH HHS K08 NS097633NINDS NIH HHS R01 NS119977Wellcome Trust
6 · The paper itself

Abstract

objectivePathogenic variants in SCN3A, encoding the voltage-gated sodium channel subunit Nav1.3, cause severe childhood onset epilepsy and malformation of cortical development. Here, we define the spectrum of clinical, genetic, and neuroimaging features of SCN3A-related neurodevelopmental disorder.

methodsPatients were ascertained via an international collaborative network. We compared sodium channels containing wild-type versus variant Nav1.3 subunits coexpressed with β1 and β2 subunits using whole-cell voltage clamp electrophysiological recordings in a heterologous mammalian system (HEK-293T cells).

resultsOf 22 patients with pathogenic SCN3A variants, most had treatment-resistant epilepsy beginning in the first year of life (16/21, 76%; median onset, 2 weeks), with severe or profound developmental delay (15/20, 75%). Many, but not all (15/19, 79%), exhibited malformations of cortical development. Pathogenic variants clustered in transmembrane segments 4 to 6 of domains II to IV. Most pathogenic missense variants tested (10/11, 91%) displayed gain of channel function, with increased persistent current and/or a leftward shift in the voltage dependence of activation, and all variants associated with malformation of cortical development exhibited gain of channel function. One variant (p.Ile1468Arg) exhibited mixed effects, with gain and partial loss of function. Two variants demonstrated loss of channel function.

interpretationOur study defines SCN3A-related neurodevelopmental disorder along a spectrum of severity, but typically including epilepsy and severe or profound developmental delay/intellectual disability. Malformations of cortical development are a characteristic feature of this unusual channelopathy syndrome, present in >75% of affected individuals. Gain of function at the channel level in developing neurons is likely an important mechanism of disease pathogenesis. ANN NEUROL 2020;88:348-362.

Indexed as

AdolescentAdultBrainChildChild, PreschoolEpilepsyFemaleFetusGenetic VariationHEK293 CellsHumansInfantMaleNAV1.3 Voltage-Gated Sodium ChannelNeurodevelopmental DisordersSodium ChannelsNAV1.3 Voltage-Gated Sodium ChannelSCN3A protein, humanSodium Channels

Identifiers

PMID32515017
PMCPMC8552104
OpenAlexW3034006522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.